Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery: Results of a survey conducted among Italian physicians

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 8, 2004, Pages 623-628

  Ageno, Walter ^a,d   Garcia, David ^b   Libby, Edward ^b   Crowther, Mark A ^c  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Elective surgery; Heart valve replacement; Low molecular weight heparin; Unfractionated heparin; Warfarin

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; DRUG MEGADOSE; ELECTIVE SURGERY; EMBOLISM; HEALTH SURVEY; LOW DRUG DOSE; MITRAL VALVE PROSTHESIS; OUTPATIENT CARE; PERIOPERATIVE PERIOD; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW;

ADMINISTRATION, ORAL; ANTICOAGULANTS; AORTIC VALVE; DATA COLLECTION; HEALTH PERSONNEL; HEART VALVE PROSTHESIS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MITRAL VALVE; PERIOPERATIVE CARE; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE;

EID: 10044255499     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200412000-00001     Document Type: Review

References (19)

1. Kearon C. Perioperative management of long-term anticoagulation. Semin Thromb Haemost 1998; 24 (suppl 1):77-83.
2. Bonow RO, Carabello B, de Leon AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998; 98:1949-1984.
3. Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, et al. Managing oral anticoagulant therapy. Chest 2001; 119:22S-38S.
4. Douketis JD. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 2002; 108:3-13.
5. Baudo F, Mostarda G, Boniardi M, for the Italian Society of Thrombosis and Haemostasis. The management of patients on long term oral anticoagulant therapy undergoing surgery. Haematologica 2002; 87(suppl II): 48-50.
6. Prisco D, Barcellona D, Baudo F, Berrettin M, Ciavarella N, Cosmi B, et al. A guide to oral anticoagulant treatment. Recommendations of the Italian Federation of Anticoagulation Clinics (FCSA). Haematologica 2003; 88(suppl 2):39-41.
7. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336:1506-1511.
8. Turpie AGG, Ageno W. Antithrombotic therapy after heart valve replacement. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ (editors): Evidence based cardiology, second edition. London: BMJ Books; 2003, pp. 832-836.
9. Acar J, Iung B, Boissel JP, Samama MM, Michel PL, Teppe JP. AREVA: multicenter randomised comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996; 94:2107-2112.
10. Horstkotte D, Schulte HD, Birks W, et al. Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical Prosthesis. J Thorac Cardiovasc Surg 1994; 107:1136-1145.
11. Akins CW. Long term results with the Medtronic-Hall valvular prosthesis. Ann Thorac Surg 1996; 61:806-813.
12. Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AG. Antithrombotic therapy in patients with mechanical or biological prosthetic heart valves. Chest 2001; 119:2203-2273.
13. Johnson J, Turpie AGG. Temporary discontinuation of oral anticoagulants: role of low molecular weight heparin [Abstract]. Thromb Haemost 2001; P2323.
14. Tinmouth A, Kovacs MJ, Cruickshank M, Brien W, Morrow B. Outpatient peri-operative and peri-procedure treatment with dalteparin for chronically anticoagulated patients at high risk for thromboembolic complications [Abstract]. Thromb Haemost 1999; 82(suppl):662.
15. Spandorfer JM, Lynch S, Weltz HH, et al. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999; 84:478-480.
16. Arizo A, Casais P, Meschengieser SS, Sanchez Luceros A, Hender M, Lazzari MA. Prospective study of the use of low molecular weight heparin vs unfractionated heparin as bridging therapy for invasive procedures in patients anticoagulated with acenocoumarol [Abstract]. Thromb Haemost 2001; 86 (Suppl) CD3646.
17. Jenkins S, Beaton K, Hart K, Yeo EL. Outpatient reversal of oral anticoagulation with low molecular weight heparin. A pilot study [Abstract]. Thromb Haemost 2001; 86 (Suppl): P1421.
18. Ferreira I, Dos L, Tornos P, Nicolau I, Permanyer-Miralda G, Soler-Soler J. Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocoumarol. Heart 2003; 89:527-530.
19. Kovacs MJ, Kahn S, Solymoss S, Ginsberg J. Prospective multicentre trial of bridging therapy with dalteparin for patients who require temporary discontinuation of OAT with prosthetic heart valves or high risk atrial fibrillation. Blood 2002; 100:559.